Heart
Heart transplant
Acute cellular rejection


Topic Completed: 18 November 2019

Revised: 18 November 2019

Copyright: 2019, PathologyOutlines.com, Inc.

PubMed Search: Acute cellular rejection[TI] heart

Alexis Musick, B.S.
Page views in 2019 to date: 156
Cite this page: Musick A, Kim A, Glass C. Acute cellular rejection. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/heartacutecellularrejection.html. Accessed December 10th, 2019.
Definition / general
  • Lymphocyte predominant infiltration of the perivascular and interstitial myocardial compartments after orthotopic heart transplantation resulting in myocyte damage and necrosis, distorted myocardial architecture and allograft dysfunction
Essential features
  • Early complication after heart transplantation (first 3 - 6 months)
  • Endomyocardial biopsy is diagnostic
  • Host T cell mediated inflammatory response to allograft differences in histocompatibility antigens, precipitating myocyte damage and myocardial dysfunction
Terminology
  • Acute allograft rejection
ICD coding
  • ICD-9: 996.83 - complications of transplanted heart
  • ICD-10: T86.21 - heart transplant rejection
Epidemiology
  • Early complication after orthotopic heart transplant causing less than 10% of 1 year mortality and 9% of 3 year mortality (Transl Res 2012;159:238)
    • Highest incidence within first 3 years after transplant, most frequently within first 3 - 6 months (Cagle: Atlas Of Transplant Pathology, 2015)
    • Up to 60% experience at least one episode within the first 6 postoperative months
  • Increased incidence / risk:
    • Donor factors: female, < 18 years old, longer ischemic time (Circulation 1992;86:II236)
    • Recipient factors: female, black, younger age, cytomegalovirus infection, higher levels of circulating donor specific antibodies to human leukocyte antigen before transplantation, greater number of previous rejection episodes (JAMA 1989;261:3561, Ann Thorac Surg 2007;84:1556)
    • Greater number of donor recipient human leukocyte antigen mismatches or sex mismatched transplantation (Transpl Int 2014;27:482)
  • Decreased risk if the transplant was received in the last 15 years
Sites
  • Inflammatory infiltrate associated with interstitial and/or perivascular compartments of allograft myocardium
  • Severe cases may involve transmural inflammation of distal coronary arteries (Cagle: Atlas Of Transplant Pathology, 2015)
Pathophysiology
  • Host allorecognition of donor major and minor histocompatibility antigens on the allograft → T cell activation → myocardial infiltration of host T cells and macrophages → myocyte damage and necrosis (Transl Res 2012;159:238)
  • More severe episodes associated with polymorphonuclear leukocyte infiltration, B cell presence and greater numbers of macrophages and dendritic cells (Cagle: Atlas Of Transplant Pathology, 2015)
    • CD4 T cells more abundant in mild / early rejection and CD8 T cells in moderate rejection (Arch Pathol Lab Med 2007;131:1169)
    • Ratio of memory (CD45RO+) to naive (CD45RA+) T cells is higher in moderate rejection than in mild rejection
  • Rejection mediated by IL-2, TNF beta and IFN gamma (Ludhwani: StatPearls, 2019)
Etiology
  • Interplay between immunologic (cellular mediated rejection and human leukocyte antigen matching) and nonimmunologic (e.g., recipient cytomegalovirus infection, pediatric donor) factors
Diagrams / tables

Images hosted on other servers:

Forms of cardiac rejection

Cardiac allograft dysfunction workup

Clinical features
Diagnosis
  • Surveillance endomyocardial biopsies (J Heart Lung Transplant 2005;24:1710)
    • In biopsy negative rejection (20%), utilize troponin, Doppler echocardiography, cardiovascular MRI, antimyosin scintigraphy, annexin V imaging or gene expression profiling (Ludhwani: StatPearls, 2019)
  • Can screen for but not diagnose rejection via noninvasive methodologies: Doppler echocardiography, cardiovascular MRI and gene expression profiling (Transl Res 2012;159:238)
    • Cannot be used as a diagnostic tool due to insufficient sensitivity and specificity
    • Gene expression profiling of peripheral blood mononuclear cells distinguished moderate severe rejection from quiescence (Am J Transplant 2006;6:150)
Radiology description
Radiology images

Images hosted on other servers:

T2 cardiac MRI

Hyperenhancement on cardiac MRI

Doppler echocardiography

Doppler strain

Prognostic factors
Case reports
  • 24 year old woman with fatal mixed humoral and cellular rejection not detected on surveillance biopsies or circulating antibodies (J Transplant 2011;2011:351950)
  • 43 year old man with asymptomatic acute cellular rejection demonstrated on cardiovascular MRI (Ann Transplant 2014;19:447)
  • 53 year old woman with fulminant mixed humoral and cellular rejection presenting with coronary pan-ischemia (Int Heart J 2015;56:679)
  • 60 year old woman with recurrent asymptomatic acute cellular rejection monitored with speckle tracing echocardiography (Pol Arch Med Wewn 2016;126:700)
  • 74 year old man with mixed humoral and cellular rejection presenting with sinus tachycardia segment elevation in leads I and aVL (Circ Heart Fail 2015;8:836)
Treatment
Microscopic (histologic) description
  • International Society for Heart and Lung Transplantation (ISHLT) 2004 standardized endomyocardial biopsy grading (J Heart Lung Transplant 2005;24:1710):
    • Grade 0R (no rejection): no evidence of cellular infiltration or myocyte damage
    • Grade 1R (mild): interstitial or perivascular infiltrate with or without 1 focus of myocyte damage
    • Grade 2R (moderate): ≥ 2 foci of infiltrate with associated myocyte damage
    • Grade 3R (severe): diffuse infiltrate with multifocal myocyte damage variable edema, vasculitis and interstitial hemorrhage
  • Inflammatory infiltrate: lymphocytes variable macrophages and eosinophils
    • Neutrophils generally absent except in severe cases
    • Presence of plasma cells suggests an alternative etiology
    • Inflammatory infiltrate is usually proportionally greater than the degree of myocyte damage
  • Myocyte damage and encroachment of inflammatory cells (→ irregular myocyte borders and distorted myocardial architecture)
    • Mild: myocytolysis (sarcoplasmic / nuclear clearing, nuclear enlargement, prominent nucleoli)
    • Severe: contraction band or coagulation necrosis
Microscopic (histologic) images

Contributed by Carolyn Glass, M.D., Ph.D.

ISHLT 0R

ISHLT 1R

ISHLT 2R

ISHLT 3R

Virtual slides

Images hosted on other servers:

Grade 2R

Grade 3R

Quilty effect and grade 1R

Grade 0R


Grade 1R

Grade 0R / late ischemic injury

Grade 0R / quilty effect / artifactual hemorrhage

Positive stains
Negative stains
  • Lack of C4d deposition on capillary endothelium on stain or immunofluorescence (presence is typical of antibody mediated rejection)
Sample pathology report
  • Heart, endomyocardial biopsy:
    • Multifocal moderate acute cellular allograft rejection with associated multifocal myocyte necrosis (ISHLT Grade 2R; 1990 Grade 3A)
    • pAMR 0: No significant evidence of antibody mediated rejection on immunohistology.
    • Quilty effect: Moderate focal endocardial inflammatory cell aggregate with myocardial encroachment.
Differential diagnosis
Board review question #1
A 42 year old black man underwent an orthotopic heart transplantation 4 months ago following viral myocarditis induced dilated cardiomyopathy in which he received a heart from a 19 year old Hispanic male. A routine posttransplant surveillance endomyocardial biopsy demonstrated mild interstitial inflammatory cell infiltrate with one small focus of myocyte damage. There was no evidence of myocyte necrosis. At that time, the patient was completely asymptomatic and reported no history of complications from his heart transplant. Which of the following is a significant risk factor in the development of this patient's disease?

  1. Donor Hispanic race
  2. Donor young age
  3. Recipient black race
  4. Sex matched transplantation
Board review answer #1
C. Recipient black race. This patient has acute cellular rejection following his orthotopic heart transplantation. Given the brief histological description of his endomyocardial biopsy, this patient has an International Society for Heart and Lung Transplantation acute cellular rejection grade of 1R. Acute cellular rejection has a peak incidence 3 - 6 months after transplantation, which aligns with this patient's current presentation. Recipient black race is associated with an increased risk/incidence of acute cellular rejection. A sex mismatched transplantation, recipient (or donor) female sex and a pediatric donor would also increase the risk / incidence of acute cellular rejection, not the inverse as presented in the answer choices for this case. Donor race has not been demonstrated to have an impact on the risk or incidence of acute cellular rejection.

Reference: Heart - Acute cellular rejection

Comment here
Board review question #2
A 20 year old man received an orthotopic heart transplant 3 months ago for restrictive cardiomyopathy. He attended his first followup visit but was unable to return to clinic for any subsequent appointments. He presented urgently today with concerns that, for the last few weeks, he has been experiencing progressive exertional dyspnea and intermittent palpitations. He also reports that he needed to use 4 to 5 pillows last night to sleep, as he felt as if he couldn't breathe well while lying flat. These symptoms have never happened before. His physician obtained an endomyocardial biopsy and a representative section (H&E) is shown below. Which of the following statements about this disease is true?



  1. Condition is mediated by B cells, which extend into the endocardium
  2. High dose IV corticosteroids are the first line therapy for this condition
  3. Invasive coronary angiography with assessment of cardiac allograft function is required to make the diagnosis
  4. Myocardial inflammatory infiltrate is predominantly composed of neutrophils
  5. Positive immunofluorescence for endothelial C4d is characteristic of the disease
Board review answer #2
E. Positive immunofluorescence for endothelial C4d is characteristic of the disease. This patient has an International Society for Heart and Lung Transplantation grade 3R acute cellular rejection following his orthotopic heart transplantation. The endomyocardial biopsy demonstrates a diffuse inflammatory infiltrate with multifocal myocyte damage, myocardial edema and interstitial hemorrhage, consistent with an International Society for Heart and Lung Transplantation grade of 3R. In acute cellular rejection, the first line therapy is high-dose IV corticosteroids. Positive immunofluorescence for C4d is characteristic of acute humoral rejection, not acute cellular rejection. Coronary angiography is used to diagnose cardiac allograft vasculopathy; in acute cellular rejection, endomyocardial biopsy is the gold standard for diagnosis. The inflammatory infiltrate in acute cellular rejection is T lymphocyte predominant and occurs primarily within the myocardium. A neutrophilic infiltrate is associated with ischemic injury while a B lymphocyte mediated process in the endocardium is consistent with a quilty lesion.

Reference: Heart - Acute cellular rejection

Comment here
Back to top